Fidelity International’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.2M | Buy |
147,937
+30,075
| +26% | +$9.81M | 0.04% | 344 |
|
|
2025
Q1 | $31.8M | Buy |
117,862
+95,796
| +434% | +$25.9M | 0.03% | 383 |
|
|
2024
Q4 | $5.19M | Buy |
22,066
+7,236
| +49% | +$1.7M | ﹤0.01% | 592 |
|
|
2024
Q3 | $4.08M | Sell |
14,830
-394
| -3% | -$108K | ﹤0.01% | 638 |
|
|
2024
Q2 | $3.7M | Buy |
15,224
+4,869
| +47% | +$1.18M | ﹤0.01% | 632 |
|
|
2024
Q1 | $1.55M | Sell |
10,355
-66,482
| -87% | -$9.94M | ﹤0.01% | 697 |
|
|
2023
Q4 | $14.7M | Sell |
76,837
-13,131
| -15% | -$2.51M | 0.02% | 452 |
|
|
2023
Q3 | $15.9M | Sell |
89,968
-16,470
| -15% | -$2.92M | 0.02% | 439 |
|
|
2023
Q2 | $20.2M | Sell |
106,438
-22,373
| -17% | -$4.25M | 0.02% | 401 |
|
|
2023
Q1 | $25.8M | Buy |
128,811
+128,807
| +3,220,175% | +$25.8M | 0.03% | 364 |
|
|
2022
Q4 | $951 | Buy |
4
+2
| +100% | +$476 | ﹤0.01% | 821 |
|
|
2022
Q3 | $0 | Buy |
+2
| New | – | ﹤0.01% | 830 |
|